![Elena Feinstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Elena Feinstein
Direttore Tecnico/Scientifico/R&S presso Quark Pharmaceuticals, Inc.
Posizioni attive di Elena Feinstein
Società | Posizione | Inizio | Fine |
---|---|---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/1998 | - |
Storia della carriera di Elena Feinstein
Formazione di Elena Feinstein
Moscow University | Doctorate Degree |
Weizmann Institute of Science | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Russia | 2 |
Israele | 2 |
Posizioni
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Borsa valori
- Insiders
- Elena Feinstein
- Esperienza